BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2907346)

  • 1. Simulating the time-course of clinical paralysis.
    Shanks CA
    Int J Clin Monit Comput; 1988; 5(4):201-5. PubMed ID: 2907346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    May JR; Rutkowski AF
    J Med Assoc Ga; 1994 Aug; 83(8):473-6, 484. PubMed ID: 7822974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose requirements of vecuronium, pancuronium, and atracurium during orthotopic liver transplantation.
    O'Kelly B; Jayais P; Veroli P; Lhuissier C; Ecoffey C
    Anesth Analg; 1991 Dec; 73(6):794-8. PubMed ID: 1683184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of vecuronium, atracurium and pancuronium in divided doses: effect on onset and duration of action.
    Brady MM; Mirakhur RK; Clarke RS
    Eur J Anaesthesiol; 1988 Jul; 5(4):243-9. PubMed ID: 2904367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal.
    Beattie WS; Buckley DN; Forrest JB
    Can J Anaesth; 1992 Nov; 39(9):925-31. PubMed ID: 1360337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between nondepolarizing neuromuscular blocking agents and inhalational anesthetics.
    Swen J; Rashkovsky OM; Ket JM; Koot HW; Hermans J; Agoston S
    Anesth Analg; 1989 Dec; 69(6):752-5. PubMed ID: 2574015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.
    Burmester M; Mok Q
    Intensive Care Med; 2005 May; 31(5):686-92. PubMed ID: 15815895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria for use of pancuronium bromide, vecuronium bromide, atracurium besylate, tubocurarine chloride, metocurine iodide, pipecuronium bromide, and doxacurium chloride in adults.
    Donnelly AJ; Golembiewski JA; Skupski R; Wojtynek JE
    Clin Pharm; 1992 May; 11(5):435-41. PubMed ID: 1349856
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of atracurium, cisatracurium and vecuronium during anaesthesia for laparoscopic surgery].
    Paśko-Majewska M; Owczuk R; Wujtewicz M
    Anestezjol Intens Ter; 2011; 43(1):9-13. PubMed ID: 21786523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1985 Nov; 57(11):1052-9. PubMed ID: 2864943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative evaluation of intubating doses of atracurium, d-tubocurarine, pancuronium and vecuronium in children.
    Montgomery CJ; Steward DJ
    Can J Anaesth; 1988 Jan; 35(1):36-40. PubMed ID: 2894902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of vecuronium and atracurium in continuous infusion. A comparative study using electromyography and accelerometry].
    Alvarez Gómez JA; Pérez Guillermo F; Bernal García G; Palacios Sánchez MA; Bernal García JJ
    Rev Esp Anestesiol Reanim; 1990; 37(2):58-62. PubMed ID: 1971119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An artificial neural network-based controller for the control of induced paralysis using vecuronium bromide.
    Kamangar FA; Behbehani K
    Ann Biomed Eng; 1997; 25(6):1040-51. PubMed ID: 9395049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of continuous infusion of vecuronium and atracurium in midline and paramedian laparotomies.
    Chaudhari LS; Shetty AN; Buddhi M; Krishnan G
    J Postgrad Med; 1999; 45(1):5-9. PubMed ID: 10734323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atracurium and vecuronium: repeated bolus injection versus infusion.
    Diefenbach C; Mellinghoff H; Grond S; Buzello W
    Anesth Analg; 1992 Apr; 74(4):519-22. PubMed ID: 1348167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacology of the neuromuscular blocking agents.
    Larijani GE; Gratz I; Silverberg M; Jacobi AG
    DICP; 1991 Jan; 25(1):54-64. PubMed ID: 1672571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
    Gibson FM; Mirakhur RK
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cisatracurium and vecuronium by infusion in neonates and small infants after congenital heart surgery.
    Reich DL; Hollinger I; Harrington DJ; Seiden HS; Chakravorti S; Cook DR
    Anesthesiology; 2004 Nov; 101(5):1122-7. PubMed ID: 15505447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery times following edrophonium and neostigmine reversal of pancuronium, atracurium, and vecuronium steady-state infusions.
    Kopman AF
    Anesthesiology; 1986 Dec; 65(6):572-8. PubMed ID: 2878631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.